Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2264867Generated: October 31, 2026

2-Propylimidazole → 9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-2-chloro-6-(2-propylimidazol-1-yl)purine

https://huagongshe.com/reaction/2264867

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-PropylimidazoleHCID 162617—
Reactant2,6-Dichloro-9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)purineHCID 10253027—
SolventAcetonitrileHCID 6342—
Product9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-2-chloro-6-(2-propylimidazol-1-yl)purineHCID 1153372593%

Reaction Conditions

Temperature65 °C

Reaction Steps

A mixture of 9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-2,6-dichloropurine (1.12 g, 2.5 mmol) and 2-propylimidazole (2.20 g, 20 mmol) was dissolved in CH3CN (30 mL) and stirred at 65° C. under N2 for 2 h (reaction complete, TLC). After removal of volatiles, the residue was dissolved in CH2Cl2 (200 mL) and washed (H2O, 3×50 mL). The aqueous phase was extracted with CH2Cl2, and the combined organic phase was dried (Na2SO4) and evaporated to dryness. The residue was chromatographed (MeOH/CH2Cl2, 1:95) to give 9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-2-chloro-6-(2-propylimidazol-1-yl)purine (977 mg, 93%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07855285B2
Source datasetuspto-grants-2010_12
ORD IDord-040e3dec56f440ec8c836c7b742e622b
Source noteuspto-grants-2010_12